Additionally, we identified frequently recurrent mutations of the LNP1, MUC16, PRSS3, and MUC3A genes, highlighting previously undetected genetic alteration in the pathogenesis of EBV+ DLBCL. This evidence concerns the gene PRSS3 and diffuse large B-cell lymphoma.